Category

Active/Enrolling

Active/Enrolling
June 19, 2019

ELI LILLY (I4V-MC-JAJA)

A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients with Rheumatoid Arthritis
Read More
Active/Enrolling
June 19, 2019

ELI LILLY (I8F-MC-GPGH)

A Randomized, Phase 3, Open-Label Trial Comparing the effect of LY3298176 versus Titrated Insulin Degludec…
Read More
Active/Enrolling
June 19, 2019

INTERCEPT PHARMACEUTICALS, INC. (747-304)

A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of…
Read More